RU99106550A - HETEROCYCLIC INHIBITORS METALLOPROTEASIS - Google Patents
HETEROCYCLIC INHIBITORS METALLOPROTEASISInfo
- Publication number
- RU99106550A RU99106550A RU99106550/04A RU99106550A RU99106550A RU 99106550 A RU99106550 A RU 99106550A RU 99106550/04 A RU99106550/04 A RU 99106550/04A RU 99106550 A RU99106550 A RU 99106550A RU 99106550 A RU99106550 A RU 99106550A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- heteroaryl
- aryl
- heteroalkyl
- compound according
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000001072 heteroaryl group Chemical group 0.000 claims 11
- 125000004404 heteroalkyl group Chemical group 0.000 claims 10
- 125000003118 aryl group Chemical group 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 9
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 6
- 125000003545 alkoxy group Chemical group 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 125000004947 alkyl aryl amino group Chemical group 0.000 claims 4
- 125000001769 aryl amino group Chemical group 0.000 claims 4
- 125000004663 dialkyl amino group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- 102000005741 Metalloproteases Human genes 0.000 claims 2
- 108010006035 Metalloproteases Proteins 0.000 claims 2
- 125000005418 aryl aryl group Chemical group 0.000 claims 2
- 125000004104 aryloxy group Chemical group 0.000 claims 2
- 125000004986 diarylamino group Chemical group 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- 206010006895 Cachexia Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 206010048592 Musculoskeletal disease Diseases 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 125000000732 arylene group Chemical group 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 150000003949 imides Chemical class 0.000 claims 1
- 101700070750 inh Proteins 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000003475 metalloproteinase inhibitor Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 230000003287 optical Effects 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
Claims (10)
где R1 представляет H;
R2 представляет водород, алкил или ацил;
Ar представляет СОR3 или SO2R4;
R3 представляет алкокси, арилокси, гетероарилокси, алкил, арил, гетероарил, гетероалкил, амино, алкиламино, диалкиламино, ариламино и алкилариламино;
R4 представляет алкил, гетероалкил, арил или гетероарил, замещенный или незамещенный;
X представляет О, S, SO, SO2 или NR5, где R5, независимо, выбирают из водорода, алкила, гетероалкила, гетероарила, арила, SO2R6, COR7, CSR8, PO(R9)2 или R5, может, необязательно, образовывать кольцо с W или Y; и
R6 представляет алкил, арил, гетероарил, гетероалкил, амино, алкиламино, диалкиламино, ариламино, диариламино и алкилариламино;
R7 представляет водород, алкокси, арилокси, гетероарилокси, алкил, арил, гетероарил, гетероалкил, амино, алкиламино, диалкиламино, ариламино и алкилариламино;
R8 представляет алкил, арил, гетероарил, гетероалкил, амино, алкиламино, диалкиламино, ариламино, диариламино и алкилариламино;
R9 представляет алкил, арил, гетероарил, гетероалкил;
W представляет водород или одну или несколько алкильных частей или алкиленовый, ариленовый или гетероариленовый мостик между двумя соседними или несоседними углеродами (образуя, таким образом, конденсированное кольцо);
Y, независимо, представляет один или несколько водородов, гидрокси, SR10, SOR4, S02R4, алкокси, амино, где амино имеет формулу NR11R12, где R11 и R12, независимо, выбирают из водорода, алкила, гетероалкила, гетероарила, арила, S02R6, СОR7, CSR8, PO(R9)2; и
R10 представляет водород, алкил, арил, гетероарил;
Z отсутствует или представляет спирочасть или оксогруппу, замещенную на гетероциклическом кольце;
n равно 1-4.1. The compound having the structure of formula (I)
where R 1 is H;
R 2 is hydrogen, alkyl or acyl;
Ar is COR 3 or SO 2 R 4 ;
R 3 is alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino and alkylarylamino;
R 4 is alkyl, heteroalkyl, aryl, or heteroaryl, substituted or unsubstituted;
X is O, S, SO, SO 2 or NR 5 , where R 5 is independently selected from hydrogen, alkyl, heteroalkyl, heteroaryl, aryl, SO 2 R 6 , COR 7 , CSR 8 , PO (R 9 ) 2 or R 5 may optionally form a ring with W or Y; and
R 6 is alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino and alkylarylamino;
R 7 represents hydrogen, alkoxy, aryloxy, heteroaryloxy, alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino and alkylarylamino;
R 8 is alkyl, aryl, heteroaryl, heteroalkyl, amino, alkylamino, dialkylamino, arylamino, diarylamino and alkylarylamino;
R 9 is alkyl, aryl, heteroaryl, heteroalkyl;
W represents a hydrogen or one or more alkyl moieties or an alkylene, arylene or heteroarylene bridge between two adjacent or non-adjacent carbons (thus forming a condensed ring);
Y, independently, represents one or more hydrogens, hydroxy, SR 10 , SOR 4 , S0 2 R 4 , alkoxy, amino, where amino has the formula NR 11 R 12 , where R 11 and R 12 are independently selected from hydrogen, alkyl , heteroalkyl, heteroaryl, aryl, S0 2 R 6 , COR 7 , CSR 8 , PO (R 9 ) 2 ; and
R 10 is hydrogen, alkyl, aryl, heteroaryl;
Z is absent or represents a spirobuty or oxo group substituted on a heterocyclic ring;
n is 1-4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60/024,846 | 1996-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU99106550A true RU99106550A (en) | 2001-04-27 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99106587A (en) | SPYROCYCLIC METALLOPROTEASES INHIBITORS | |
RU99106522A (en) | SUBSTITUTED CYCLIC AMINUM METHODIC PROTEASIS INHIBITORS | |
RU2221782C2 (en) | Substituted cyclic amine-type metalloprotease inhibitors | |
CA2345297A1 (en) | Synthetic analogs of ecteinascidin-743 | |
RU2000127751A (en) | ANTI-TUMOR MEDICINE | |
JP2002534523A5 (en) | ||
UY26512A1 (en) | NON-PEPTIDIC INHIBITORS OF THE VLA-DEPENDENT CELLULAR UNION - 4 USEFUL IN THE TREATMENT OF INFLAMMATORY, AUTOIMMUNE AND RESPIRATORY DISEASES | |
CA2078790A1 (en) | 3-benzylidene-1-carbamoyl-2-pyrrolidone analogues | |
NO965568D0 (en) | Arylsylphonamido substituted hydroxamic acids as matrix metalloproteinase inhibitors | |
RU94036774A (en) | INHIBITION OF PROLIFERATION OF SMOOTH MUSCLE CELLS AND RESTENOSIS | |
BR9908325A (en) | 6 9-disubstituted 2- [trans-4 (4-aminocyclohexyl) amino] purines | |
NO991494D0 (en) | <beta> -sulfonylhydroxamic acids as matrix metalloproteinase inhibitors | |
ATE120955T1 (en) | BENZYLIDENE-MALONONITRILE DERIVATIVES FOR INHIBITING PROLIFERATIVE PROCESSES IN MAMMAL CELLS. | |
RU93004675A (en) | 1,2,4-Oxadiazolyl-phenoxyalkylisoxazoles, their use as antiviral agents, pharmaceutical composition | |
CO5261493A1 (en) | PROCEDURE AND COMPOUNDS FOR THE INHIBITION OF MRP1 | |
RU95117068A (en) | ANTIHYPERTRIGLICYRIDEMIC COMPOSITION, METHOD FOR PRODUCING IT, METHOD FOR TREATING OR PREVENTION OF HYPERTRIGLYCERIDEMIA, USE OF COMPOUNDS | |
RU97117350A (en) | INTIMA HYPERTROPHY INHIBITOR, OXINDOL DERIVATIVE APPLICATION FOR THE INIMA HYPERTROPHY INHIBITOR INHIBITOR, A COMPOSITION FOR INHIBITING INTIMA HYPERTROPHY, PREVENTION AND TREATMENT HYPERT | |
KR960037662A (en) | Arylalkyl-paridazine derivatives | |
KR910007883A (en) | Quinoline derivatives, preparation method and use thereof | |
YU7191A (en) | ORALLY ACTIVE RENIN INHIBITORS | |
NO890440L (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ISOKINOLINE DERIVATIVES. | |
RU99106550A (en) | HETEROCYCLIC INHIBITORS METALLOPROTEASIS | |
RU99106665A (en) | 1,4-HETEROCYCLIC INHIBITORS METALLOPROTEAS | |
ES557512A0 (en) | PROCEDURE FOR OBTAINING 1-ARIL-4-NITROPIRAZOLES | |
RU96101173A (en) | PYRIDASINON DERIVATIVES |